CAS: 97232-97-8; Cefuroxime

该化合物是乙氧基乙基乙醇二代甲状腺素抗生素的衍生物,其特征是将乙基氧乙基组从母分子中去除,导致药用动力特性改变,显示出广泛频谱的抗菌性活动,特别是针对抗克菌阳性病原体和某些克微阴性病体的抗生性活动;该改变会增强稳定性,并可能影响生物利用率,使其成为药物研究的一个主题;其行动机制包括抑制细菌细胞壁合成,使其对β-乳酶生产菌株有效;该衍生物主要用于潜在的治疗用途,包括改进药物的交付或减少与常规乙氧制剂相比的副作用.

结构式图片

MSDS等安全信息

    上下游产品

    Cefuroxime trans-cefuroxime axetil is°Cyanate de chlorosulfonyle (Z)-2-methoxyimino-2-(furyl-2-yl)acetic acid ammonium saltCefuroxime

    合成工艺路线路线简述

    • 97170-19-9 + 1189-71-5 = 97232-97-8
      反应条件:1.1 Solvents: Ethyl Acetate; 40 Min,-50 - -40 °C1.2 Solvents: Water; 30 Min,-50 - -40 °C1.3 Reagents: Sodium Bicarbonate Solvents: Water; Ph 1.8
      标题:Preparation Method Of Trans-Cefuroxime Derivative
      参考文献:China
    头孢呋辛 以 甲醇,水 作为反应溶剂,化学反应生成 去乙基乙酸酯(E)-头孢呋辛酯
    参考文献:头孢呋辛酯及相关化合物的光异构化动力学
    标题:头孢呋辛酯及相关化合物的光异构化动力学
    摘要:用HPLC研究了头孢呋辛酯水溶液在254 Nm下的光致异构化动力学.总体降解是烷氧基亚氨基基团的异构化与β-内酰胺环的光解之间竞争的结果.头孢呋辛酯以两种非对映异构体的混合物形式存在,并显示出不同的反应速率.这不仅适用于光异构化步骤,而且适用于碱性条件下的基态水解.头孢呋辛酯的抗异构体及其某些降解产物也观测到了烷氧基亚氨基的光异构化.所有这些光异构化的量子产率始终低于1%,这说明了光解步骤的相对重要性.头孢呋辛酯的固定顺式与反比为1,头孢呋辛为2.1.从这项研究和以前的研究来看,与其他带有烷氧基亚氨基的抗生素相比,头孢呋辛酯在254 Nm照射下最敏感.氨曲南最稳定,其次是头孢噻肟,头孢呋辛和头孢呋辛酯.
    DOI:10.1002/jps.2600830422

    海关参考信息

    专利信息


    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-2024197774-A1
    优先权日:2021-04-16
    标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
    发明人:LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO
    权利人:UNIV TEXAS
    摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.

    专利号:US-6777553-B1
    优先权日:2003-03-25
    标题 :Process for synthesis of bis-(substituted-4-quinolyl) disulphides
    发明人:MESHRAM HARSHADAS MITARAM; KOKKU PREMALATHA; AYYAGIRI VENKATA MADHAVI; BEGARI ESHWARAIAH; YADAV JHILLU SINGH
    权利人:COUNCIL SCIENT IND RES
    摘要:The present invention relates to a process for the synthesis of bis-(substituted-4-quinolyl) disulphides.

    专利号:US-2005186197-A1
    优先权日:2002-08-29
    标 题:Peptide inhibitors of beta lactamases
    发明人:PALZKILL TIMOTHY; HUANG WANZHI
    摘要:Peptide inhibitors of β-lactamases have been identified by the synthesis of peptide arrays using synthesis SPOT technology. These peptide inhibitors of β-lactamase have activity against a broad spectrum of β-lactamases and are useful in a variety of applications.

    专利号:US-8557979-B2
    优先权日:2004-06-10
    标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
    发明人:CHOI WOO-BAEG; KOWALIK EWA
    权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
    摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.

    专利号:WO-0034289-A1
    优先权日:1998-12-08
    标 题:Process of preparing esters of penicillanic acid sulfoxide
    发明人:GARDNER JOHN PAUL; ZHANG TONY YANTAO
    权利人:LILLY CO ELI; GARDNER JOHN PAUL; ZHANG TONY YANTAO
    摘要:A new synthesis of penicillanic sulfoxide acid ester is claimed. The synthesis starts with 6-amino penicillanic acid and proceeds through conversion to a bromide via diazotization, esterification, reduction of the bromide, and oxidation of the resulting penicillanic ester.
    珠海优润医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zhyourun.com/
    电话: 0756-6811852👤
    📞珠海优润医药科技有限公司 ⚠️参考联系方式

    销售电话:0756-6811852
    邮箱:zhyrpharm_sales03@126.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1128/aac.31.10.1579
    摘要:Yajko DM, Nassos PS, Hadley WK. Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother. 1987 Oct;31(10):1579–84.
    摘要:S61 | UJICCSLIB | Collision Cross Section (CCS) Library from UJI | DOI:10.5281/zenodo.3549476
    摘要:S6 | ITNANTIBIOTIC | Antibiotic List from the ITN MSCA ANSWER | DOI:10.5281/zenodo.2621956
    摘要:Ross et al. JASMS 2022; 33; 1061-1072. DOI:10.1021/jasms.2c00111
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知